Inflammation and coagulation: Direct mediators of physical function in the elderly?

American Journal of Medicine

Volumn 114, Issue 3, 2003, Pages 235-236

  Marenberg, Marjorie E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; INTERLEUKIN 6;

AGED; BLOOD CLOTTING; BLOOD SAMPLING; COHORT ANALYSIS; CYTOKINE PRODUCTION; DAILY LIFE ACTIVITY; DISEASE MARKER; EDITORIAL; ELDERLY CARE; FIBRINOLYSIS; HEALTH STATUS; HUMAN; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE; THROMBOSIS;

EID: 0037440758     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00039-1     Document Type: Editorial

References (21)

1. Ridker P., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 342:2000;836-843.
2. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 347:2002;1557-1565.
3. Kuller L.H. Serum levels of IL-6 and development of disability in older persons. J Am Geriatr Soc. 47:1999;755-756.
4. Ferrucci L., Harris T., Guralnik J., et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 47:1999;639-646.
5. Harris T.B., Ferrucci L., Tracy R.P., et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
6. Cohen H.J., Pieper C.F., Harris T., Rao K.M., Currie M.S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 52:1997;M201-M208.
7. Folsom A.R., Aleksic N., Park E., Salomaa V., Juneja H., Wu K.K. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol. 21:2001;611-617.
8. Koenig W., Rothenbacher D., Hoffmeister A., Griesshammer M., Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol. 21:2001;1701-1705.
9. Danesh J., Whincup P., Walker M., et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 103:2001;2323-2327.
10. Pieper C.F., Rao K.M., Currie M.S., Harris T.B., Chen H.J. Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci. 55:2000;M649-M657.
11. Harris T. Sarcopenia and disability in perspective. Gerontologist. 42:2002;52.
12. Cohen HJ, Harris T, Pieper CF. Coagulation and inflammatory pathway activation in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:000-000.
13. Cushman M., Lemaitre R.N., Kuller L.H., et al. Fibrinolytic activation markers predict myocardial infarction in the elderly: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 19:1999;493-498.
14. Lowe G.D., Yarnell J.W., Rumley A., Bainton D., Sweetnam P.M. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol. 21:2001;603-610.
15. Rader D.J. Inflammatory markers of coronary risk. N Engl J Med. 343:2000;1179-1182.
16. Newman A.B., Gottdiener J.S., McBurnie M.A., et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 56:2001;M158-M166.
17. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 57:2002;M326-M332.
18. Jenny N.S., Tracy R.P., Ogg M.S., et al. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 22:2002;2066-2071.
19. Margaglione M., Grandone E., Mancini F.P., Di Minno G. Genetic modulation of plasma fibrinogen concentrations: possible importance of interleukin-6. J Thromb Thrombolysis. 3:1996;51-56.
20. Hamerman D. Toward an understanding of frailty. Ann Intern Med. 130:1999;945-950.
21. Binder E.F., Schechtman K.B., Ehsani A.A., et al. Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc. 50:2002;192-192.